Lexeo Therapeutics, Inc. (LXEO)

NASDAQ: LXEO · Real-Time Price · USD

Compare

8.91

-0.18 (-1.98%)

At close: Nov 20, 2025, 4:00 PM EST

8.86

-0.05 (-0.54%)

After-hours: Nov 20, 2025, 5:27 PM EST

Lexeo Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep '25 Sep 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020
Cash & Equivalents	41	35.01	121.47	77.34	135.86	29.37
Short-Term Investments	81.77	86.5	-	-	-	-
Cash & Short-Term Investments	122.76	121.52	121.47	77.34	135.86	29.37
Cash Growth	-21.82%	0.04%	57.06%	-43.08%	362.53%	-
Prepaid Expenses	5.03	4.6	2.83	2.34	0.13	-
Other Current Assets	-	-	-	0.37	0.7	0.03
Total Current Assets	127.79	126.12	124.29	80.05	136.68	29.41
Property, Plant & Equipment	9.41	10.56	12.26	13.78	0.17	-
Long-Term Investments	3.39	7.01	-	-	-	-
Other Long-Term Assets	3.25	3.25	3.25	3.25	0	0
Total Assets	143.84	146.94	139.81	97.08	136.86	29.41
Accounts Payable	4.66	6.42	3.79	2.68	3.06	0.04
Accrued Expenses	9.69	12.82	10.29	8.09	3.78	0.25
Current Portion of Leases	2.72	2.67	2.61	2.83	-	-
Current Income Taxes Payable	-	-	-	0.51	0.53	0.04
Current Unearned Revenue	-	-	-	-	0.05	0.14
Other Current Liabilities	0.21	0.94	0.55	0.24	0.03	0.22
Total Current Liabilities	17.27	22.85	17.24	14.35	7.45	0.7
Long-Term Leases	5.74	7.25	9.03	10.65	-	-
Other Long-Term Liabilities	-	-	-	-	-	3.01
Total Liabilities	23.01	30.1	26.27	25	7.45	3.71
Common Stock	0.01	0	0	-	0	0
Additional Paid-In Capital	479.97	397.13	295.37	2.49	0.57	0.01
Retained Earnings	-359.22	-280.17	-181.84	-115.45	-56.17	-5.55
Treasury Stock	-0.02	-0.02	-	-	-	-
Comprehensive Income & Other	0.09	-0.1	-	-	-	-
Total Common Equity	120.83	116.84	113.54	-112.95	-55.6	-5.54
Shareholders' Equity	120.83	116.84	113.54	72.08	129.41	25.7
Total Liabilities & Equity	143.84	146.94	139.81	97.08	136.86	29.41
Total Debt	8.46	9.92	11.64	13.48	-	-
Net Cash (Debt)	114.31	111.59	109.83	63.85	135.86	29.37
Net Cash Growth	-22.04%	1.61%	72.00%	-53.00%	362.53%	-
Net Cash Per Share	2.67	3.51	20.51	39.17	87.50	20.38
Filing Date Shares Outstanding	72.99	33.2	26.65	1.61	1.58	1.51
Total Common Shares Outstanding	54.93	33.07	26.65	1.61	1.58	1.51
Working Capital	110.52	103.28	107.06	65.7	129.24	28.71
Book Value Per Share	2.20	3.53	4.26	-70.28	-35.18	-3.66
Tangible Book Value	120.83	116.84	113.54	-112.95	-55.6	-5.54
Tangible Book Value Per Share	2.20	3.53	4.26	-70.28	-35.18	-3.66
Machinery	1.63	1.23	0.89	0.65	0.19	-
Leasehold Improvements	0.27	0.27	0.25	0.23	-	-

Updated Nov 5, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q